Iconic former Uruguayan President Jose Mujica says he has esophageal cancer
SANTIAGO, Chile (AP) — Uruguay’s former guerilla-turned-president, Jose Mujica, best known for transforming his tiny country into one of the most socially liberal in all of Latin America, said Monday that he has esophageal cancer.
Mujica, 88, said he was diagnosed during a routine medical checkup last Friday. He said the tumor discovered in his esophagus is particularly dangerous because he also suffers from an autoimmune disease.
“This is obviously very complicated and doubly so in my case,” the former president told reporters on Monday, adding that doctors were assessing the best course of action but told him chemotherapy and surgery posed challenges.
Better known as “Pepe” Mujica, the former president — once the leader of the Tupamaros, the Marxist urban guerrilla group that drew inspiration from the Cuban revolution — governed Uruguay from 2010 and 2015.
Related articles
College baseball notebook: Conference tournaments to decide NCAA automatic bids and many at
The field for the NCAA baseball tournament will take shape this week with conference tournaments det2024-05-21Xi leads China in boosting tech self
By Wang Cong and Chi Jingyi (Global Times) 09:48, May 31, 2023On a sweltering Friday afternoon, cran2024-05-21Varsho hits 2nd career slam, Rodríguez fans 6 in debut as Blue Jays beat Rockies 5
TORONTO (AP) — Daulton Varsho hit his second career grand slam, Yariel Rodríguez struck out six over2024-05-21Infographic: Xizang witnesses astounding development 72 years after peaceful liberation
(Global Times) 09:35, May 23, 2023Editor's note:On May 23, 1951, the Agreement of the Central People2024-05-21Insider Q&A: CIA's chief technologist's cautious embrace of generative AI
Knowledge advantage can save lives, win wars and avert disaster. At the Central Intelligence Agency,2024-05-21Chinese path to modernization carries global significance (7)
(People's Daily Online) 11:20, April 28, 2023Pakistani Ambassador to China Moin ul Haque believes th2024-05-21
atest comment